Stopping vs. Continuing Aspirin before Coronary Artery Surgery | Zendy

Paul S. Myles | Zendy; Julian A. Smith | Zendy; Andrew Forbes | Zendy; Brendan Silbert | Zendy; Mohandas Jayarajah | Zendy; Thomas Painter | Zendy; D. James Cooper | Zendy; Silvana Marasco | Zendy; John J. McNeil | Zendy; Jean S. Bussières | Zendy; Sophie Wallace | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Stopping vs. Continuing Aspirin before Coronary Artery Surgery

Author(s) -

Paul S. Myles,

Julian A. Smith,

Andrew Forbes,

Brendan Silbert,

Mohandas Jayarajah,

Thomas Painter,

D. James Cooper,

Silvana Marasco,

John J. McNeil,

Jean S. Bussières,

Sophie Wallace

Publication year - 2016

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa1507688

Subject(s) - medicine , aspirin , myocardial infarction , coronary artery disease , cardiology , stroke (engine) , artery , surgery , mechanical engineering , engineering

Most patients with coronary artery disease receive aspirin for primary or secondary prevention of myocardial infarction, stroke, and death. Aspirin poses a risk of bleeding in patients undergoing surgery, but it is unclear whether aspirin should be stopped before coronary artery surgery.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research